Cargando…
Recent trends in the treatment of chronic hepatitis C
Pegylated interferon and ribavirin combination therapy is accepted as the standard antiviral treatment for chronic hepatitis C regardless of HCV genotype. This combination therapy achieves higher response rates than previous therapy, but, nevertheless, a large proportion of patients suffer from trea...
Autores principales: | Jun, Dae Won, Tak, Won Young, Bae, Si Hyun, Lee, Youn Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326995/ https://www.ncbi.nlm.nih.gov/pubmed/22511899 http://dx.doi.org/10.3350/kjhep.2012.18.1.22 |
Ejemplares similares
-
Cost-effectiveness of chronic hepatitis C screening and treatment
por: Lee, Hye Won, et al.
Publicado: (2022) -
Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019) -
New treatments for chronic hepatitis C
por: Jang, Jae Young, et al.
Publicado: (2010) -
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
por: Woo, Hyun Young, et al.
Publicado: (2020) -
Chronic Hepatitis C
por: Jang, Jae Young, et al.
Publicado: (2011)